Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Distillery Therapeutics

Inhibition of calprotectin for vascular calcification in chronic kidney disease

September 14, 2023 8:02 PM UTC

Inhibition of calprotectin, a circulating damage-associated molecular pattern protein, could help treat vascular calcification in chronic kidney disease by blocking calprotectin-induced activation of TLR4 and RAGE.

Levels of calprotectin subunits S100A8 and S100A9 and total calprotectin protein were higher in the serum of chronic kidney disease patients who developed cardiovascular complications than in serum from patients without cardiovascular complications, and were associated with increased levels of vascular calcification. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article